In the present times, the big pharma companies have started a lot of research and development in the area of drugs that are effective in the cure of various deadly diseases. It is a good news for the patients of HepatitisC that the pharma major NATCO Pharma has received an approval from the government for the manufacture of generic Hepcinat Sofosbuvir.
The company is listed both in the NSE and the drug controller general has given this company the approval for the manufacture of Hepcinat tablets. In fact, Natco Pharma is the first company that has received such an approval. After getting the approval for generic Sofosbuvir tablets the company shares has also increased.
A Hepcinat Sofosbuvir tablet is a new chronic hepatitis C medicine that is generally used for hepatitis C infection.
The NATCO Hepcinat Sofosbuvir 400mg, is a medicine that is used for the cure of the chronic hepatitis C and in the international markets, it is sold by the Gilead sciences that comes under the brand called Sovaldi.
The NATCO Pharma Company will market this particular tablet under the brand called Hepcinat Sofosbuvir and this will be through the strategic partnership as far as India is concerned and the price per bottle for the drug has been fixed close to INR 20 thousand. The agreement that the company has signed with the Gilead sciences is a non licensing agreement and the drug will be sold in the ninety one non developed nations of the globe.
Aurel Pharmaceuticals is one of the leading Hepcinat Sofosbuvir 400mg supplier, exporter in India
So far the Hepcinat price in India is constant but there will be a slight deviation in the price range of the drug when it comes to the international markets. The company NATCO pharma will apply for the special license but so far the supreme court of India has not given any positive nod in this matter. The truth is that the company has made the food profits since the past two years.
The company Natco that is the maker of the flagship Hepcinat products has the experience of creating the drugs since the past thirty years and the creation of the Hepcinat tablet is literally the feather in the crown of the company. So far, ten leading products that have been researched and developed by the company have been successfully commercialised in the USA.
The interesting fact is that the company follows the partnership driven business and that is one of the pillars of its success as far as the international markets are concerned. The team of expert pharmacists possessing the drug research experience have led to the successful development of the product called the Hepcinat 400 mg and this is really an achievement as far as the cure of Hepatitis C is concerned. It is advised the drug be taken under the supervision of the medical expert and the patients who have other diseases apart from the Hepatitis C do necessarily need the intervention of the medical doctors prior to the use of Hepcinat tablet 400 mg.